Tus kws kho mob
P35-19 Appeals Policy for no Prior Authorization Effective June 3, 2019
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 01, 2019
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 2841 - 2850 ntawm 4138
Tus kws kho mob
QP30-19 Pharmacy Benefit Update – New Drug-Related Prior Authorization with Quantity Limit Criteria: Hereditary transthyretin-mediated (hATTR) Amyloidosis Neuropathy
Hnub Tim pib siv tau lub khoos kas: Lub Peb Hlis Ntuj Tim 27, 2019
Tus kws kho mob
QP33-19 SmartChoice Program for Fully Insured Commercial Products
Hnub Tim pib siv tau lub khoos kas: Lub Peb Hlis Ntuj Tim 27, 2019
Tus kws kho mob
QP32-19 Pharmacy Benefit Exclusion for Glyrx-PF, Libtayo, Lumoxiti, Onpattro, Poteligeo, and Xerava
Hnub Tim pib siv tau lub khoos kas: Lub Peb Hlis Ntuj Tim 27, 2019
Tus kws kho mob
QP34-19 Pharmacy Benefit Exclusion for Antineoplastic and Adjunctive Therapies
Hnub Tim pib siv tau lub khoos kas: Lub Peb Hlis Ntuj Tim 27, 2019
Tus kws kho mob
QP31-19 Change to Outpatient Therapies Prior Authorization Requirements for Medicare Advantage Subscribers
Hnub Tim pib siv tau lub khoos kas: Lub Peb Hlis Ntuj Tim 27, 2019
Tus kws kho mob
QP29-19 Pharmacy Benefit Update – New Drug-Related Prior Authorization with Quantity Limit Criteria: Arikayce
Hnub Tim pib siv tau lub khoos kas: Lub Peb Hlis Ntuj Tim 27, 2019
Tus kws kho mob
QP23-19 Reminder Payment Policy Auditing System
Hnub Tim pib siv tau lub khoos kas: Lub Peb Hlis Ntuj Tim 13, 2019
Tus kws kho mob
QP28-19 Interest Paid on Clean Claims
Hnub Tim pib siv tau lub khoos kas: Lub Peb Hlis Ntuj Tim 13, 2019
Tus kws kho mob
QP24-19 New Behavioral Health Coding for Early Intensive Behavioral Intervention (EIBI) Services for Commercial Lines of Business
Hnub Tim pib siv tau lub khoos kas: Lub Peb Hlis Ntuj Tim 13, 2019